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Abstract: Ergot alkaloids are pharmaceutically and agriculturally important secondary 
metabolites produced by several species of fungi. Ergot alkaloid pathways vary among 
different fungal lineages, but the pathway intermediate chanoclavine-I is evolutionarily 
conserved among ergot alkaloid producers. At least four genes, dmaW, easF, easE, and 
easC, are necessary for pathway steps prior to chanoclavine-I; however, the sufficiency of 
these genes for chanoclavine-I synthesis has not been established. A fragment of genomic 
DNA containing dmaW, easF, easE, and easC was amplified from the human-pathogenic, 
ergot alkaloid-producing fungus Aspergillus fumigatus and transformed into  
Aspergillus nidulans, a model fungus that does not contain any of the ergot alkaloid 
synthesis genes. HPLC and LC-MS analyses demonstrated that transformed A. nidulans 
strains produced chanoclavine-I and an earlier pathway intermediate. Aspergillus nidulans 
transformants containing dmaW, easF, and either easE or easC did not produce 
chanoclavine-I but did produce an early pathway intermediate and, in the case of the easC 
transformant, an additional ergot alkaloid-like compound. We conclude that dmaW, easF, 
easE, and easC are sufficient for the synthesis of chanoclavine-I in A. nidulans and 
expressing ergot alkaloid pathway genes in A. nidulans provides a novel approach to 
understanding the early steps in ergot alkaloid synthesis. 
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Ergot alkaloids are tryptophan-derived mycotoxins produced by several different fungi and have 
proven to be both pharmaceutically and agriculturally important. Several Claviceps, Neotyphodium, 
and Epichloë species of the order Hypocreales produce a variety of complex ergot alkaloids [1,2]. 
Aspergillus fumigatus and Penicillium commune of the order Eurotiales also are capable of ergot 
alkaloid synthesis; however, their ergot alkaloid profiles differ considerably from those of the 
Hypocrealean ergot alkaloid producers [2,3]. Ergot alkaloid-producing fungi contain an ergot alkaloid 
synthesis (eas) gene cluster with a set of core genes that is well conserved [1–4]. The eas clusters of 
the various ergot alkaloid producers also contain variable, lineage-specific genes that result in the 
formation of different pathway products among lineages [2,4]. The steps of ergot alkaloid synthesis 
leading to the formation of chanoclavine-I (the earliest ergot alkaloid pathway biosynthetic 
intermediate observed accumulating in most producers) (Figure 1) are believed to be evolutionarily 
conserved among the different fungi that produce ergot alkaloids [1–4]; however, the identity and 
catalytic activities of all the genes required for chanoclavine-I synthesis have not yet been determined.  
Figure 1. Early steps of the ergot alkaloid pathway. Genes controlling specific  
steps are listed beside arrows. Abbreviations: DMAPP = dimethylallyldiphosphate;  
Trp = tryptophan; DMAT = dimethylallyltryptophan. Unresolved steps are indicated in red. 
 
Based on the proposed biochemical scheme of Kozikowski et al. [5], the synthesis of  
chanoclavine-I occurs in at least five steps. Gene knockout and heterologous expression studies have 
demonstrated that at least four genes, dmaW, easF, easE, and easC, are required prior to  
chanoclavine-I [6–9]. However, it is currently unknown whether these genes are sufficient to 
synthesize chanoclavine-I. DMAT synthase, the product of dmaW, catalyzes the initial prenylation 
reaction to yield dimethylallyltryptophan (DMAT) [6,10,11], and easF encodes a methyltransferase 
that N-methylates DMAT to form the second intermediate, N-Me-DMAT [7]. The order of activity and 
function of EasE and EasC have not been established, though gene knockout studies indicate these 
enzymes are necessary for the conversion of N-Me-DMAT to chanoclavine-I [8,9]. Based on their 
sequences, easE encodes an oxidoreductase and easC encodes a catalase. Involvement of additional 
enzymes cannot be excluded because the synthesis of chanoclavine-I requires two two-electron 
oxidations, and EasE is the only oxidoreductase among the four required genes. However, the eas 
clusters in the diverse fungi that produce ergot alkaloids do not contain any additional conserved 
oxidoreductase genes for which a function has not been assigned. Thus, the question of sufficiency of 
the four required genes is unresolved.  
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Aspergillus fumigatus is a common saprophytic fungus and potentially fatal pathogen in 
immunocompromised individuals [12]. Ergot alkaloid synthesis genes are clustered in the  
A. fumigatus genome [10,11] and are expressed during asexual reproduction [13,14].  
Aspergillus nidulans, a model fungus that is closely related to A. fumigatus, does not contain the ergot 
alkaloid gene cluster nor does it produce ergot alkaloids. The primary objective of this study was to 
test if dmaW, easF, easC, and easE are sufficient to direct chanoclavine-I synthesis in A. nidulans.  
We used a novel approach to test the sufficiency of the genes by transforming A. nidulans with  
dmaW, easF, easC, and easE, or subsets of those genes, from A. fumigatus under the control of their 
native promoters.  
2. Results 
2.1. Engineering of Chanoclavine-I Producing Strains of A. nidulans  
An 8.8-kb fragment of A. fumigatus DNA containing the genes dmaW, easF, easE, and easC was 
successfully amplified by PCR and integrated into the genome of two A. nidulans transformants, 
yielding strains WFEC33 and WFEC35. The presence of each of the four A. fumigatus genes in the 
WFEC strains was verified by PCR primed from internal gene primer-annealing sites (Figure 2). The 
recipient strain A. nidulans A767 did not contain any of the four genes. The absence of the ergot 
alkaloid gene cluster in A. nidulans was further supported by the lack of sequences with an E value less 
than 10 in a BLASTn search between the A. fumigatus dmaW, easF, easE, and easC cluster sequence 
with the genome of A. nidulans FGSC A4. 
Figure 2. Ergot alkaloid synthesis genes. (a) The ergot alkaloid gene cluster of  
A. fumigatus. Genes expressed in A. nidulans in this study are shown in red; (b) PCR 
verification of the presence or absence of dmaW, easF, easE, and easC from wild type and 
mutant strains. Each gene was independently amplified from internal primer binding sites. 
Relative mobility of relevant BstEII-digested bacteriophage lambda fragments (sizes in kb) 
is indicated to the left of the gel. 
 
Both WFEC strains and A. nidulans A767 were analyzed by HPLC with fluorescence detection to 
investigate the presence of ergot alkaloids. Transformed strains accumulated an analyte that co-eluted 
with chanoclavine-I at approximately 33 min, whereas A. nidulans A767 did not (Figure 3). Extracts of 
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WFEC35 and A. nidulans A767 also were analyzed by electrospray ionization (ESI) LC-MS in 
positive mode. Again WFEC35 contained a peak that co-eluted with chanoclavine-I standard. The 
analyte had an m/z of 257.1 consistent with the [M + H]+ of chanoclavine-I (Figure 4). HPLC with 
fluorescence detection of mutant strain WFEC35 also revealed the presence of the early pathway 
intermediate N-Me-DMAT which eluted at approximately 44 min (Figure 3). The identity of this 
analyte as N-Me-DMAT was supported by an ion of m/z 287.1 in ESI LC-MS analyses (corresponding 
to [N-Me-DMAT + H]+) and by co-elution with authentic standard (Figure 4).  
Conidiating cultures produced modest quantities of chanoclavine-I. Aspergillus nidulans strain 
WFEC35 produced approximately 0.3 fg chanoclavine-I per conidium, or about 3 ng chanoclavine-I 
per mm2 of culture surface area and comparable quantities of N-Me-DMAT. Strain WFEC33 produced 
lesser quantities of chanoclavine-I and did not accumulate measurable quantities of N-Me-DMAT.  
Figure 3. HPLC analyses of A. nidulans strain WFEC35 (transformed with dmaW,  
easF, easE, and easC), A. nidulans FGSC A767, and chanoclavine-I standard. Ch, 
chanoclavine-I; N, N-Me-DMAT. Fluorescence properties were observed with an 
excitation wavelength of 272 nm and an emission wavelength of 372 nm. 
 
Figure 4. LC-MS analysis of A. nidulans extracts. Chromatograms display presence and 
elution time of molecules with an m/z value of 257 ± 0.5 (left column) or 287 ± 0.5 (right 
column). Chromatograms of A. nidulans strains A767 and WFEC35 were normalized to the 
intensity of the highest peak in the WFEC35 trace for each analyte. The N-Me-DMAT 
standard chromatogram is displayed at a higher sensitivity because of paucity of material 
available. Inserts show the mass spectrum of the major peak in each chromatogram. 
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2.2. Engineering of A. nidulans Strains Expressing Subsets of Early Pathway Genes  
Two additional mutant strains of A. nidulans were generated by transformation with subsets of three 
of the four ergot alkaloid cluster genes: strains WFC (containing dmaW, easF, and easC) and WFE 
(containing dmaW, easF, and easE). The presence of each gene in the genomes of the different mutants 
was verified by PCR (Figure 2). Chanoclavine-I was not detectable by HPLC (Figure 5) or ESI LC-MS 
(data not shown) in either strain. Expression of dmaW and easF from the inserted construct in both 
strains was validated by the accumulation of the early pathway intermediate, N-Me-DMAT, which 
eluted from the column at approximately 44 min (Figure 5). In addition, WFC cultures accumulated a 
novel molecule with an elution time of 41 min and that had an m/z value of 259.0 in ESI LC-MS 
analyses. The unidentified metabolite displayed a higher fluorescence at excitation and emission 
wavelengths of 310 nm and 410 nm, respectively, than at 272 nm excitation and 372 nm emission 
settings (Figure 5). Ergot alkaloids with a double bond between carbons 9 and 10 of the ergot alkaloid 
ring system fluoresce stronger at the 310 nm (excitation) and 410 nm (emission) setting compared to 
their fluorescence at the 272 nm/372 nm setting; conversely, ergot alkaloids with a  
8,9 double bond or those lacking a double bond at either of those positions fluoresce stronger at the 
272 nm/372 nm setting [15]. The novel alkaloid was not produced in sufficient quantities to allow the 
acquisition of additional structural data at this time.  
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Figure 5. Fluorescence HPLC analysis of WFC and WFE mutant cultures.  
(a) Chromatogram with excitation at 310 nm and emission at 410 nm; (b) Chromatogram 
with excitation at 272 nm and emission at 372 nm; (c) Generic ergoline ring system with 
double bond between carbons 9 and 10; (d) Generic ergoline ring system with double bond 
between carbons 8 and 9. Ch, chanoclavine-I; N, N-Me-DMAT; U, Unknown unique to 
strain WFC.  
 
3. Discussion 
Our results describe the first transfer of ergot alkaloid biosynthetic capability to a previously  
non-producing fungus. These data also indicate that dmaW, easF, easE, and easC are sufficient for  
A. nidulans to synthesize chanoclavine-I. Since the pathway leading to the formation of chanoclavine-I 
appears to be evolutionarily conserved, the knowledge gained from this study will not only apply to  
A. fumigatus but theoretically to all ergot alkaloid producers. Despite the large amount of research 
conducted on ergot alkaloid synthesis, the formation of chanoclavine-I has yet to be completely 
understood. Only two steps in this evolutionarily conserved portion of the pathway have been 
completely characterized—those controlled by dmaW and easF [6,7,10,11]. After the formation of  
N-Me-DMAT, the order of activity and catalytic functions of enzymes is not clear. Our data indicate 
that EasE and EasC individually are necessary and together are sufficient to convert N-Me-DMAT to 
chanoclavine-I. Nonetheless, the observations in this study do not rule out the possibility that  
A. nidulans naturally possesses an enzyme that also contributes to the formation of chanoclavine-I 
from N-Me-DMAT. Despite the fact that all known ergot alkaloid genes are clustered in A. fumigatus 
and other ergot alkaloid-producing fungi [1–4,15], we cannot presently exclude the possibility  
that a required gene in the pathway may be located elsewhere in the genome and common to  
non-producing fungi.  
Transformations with subsets of three of the four studied genes, combining alternately easC or easE 
with the combination of dmaW and easF, did not yield strains capable of producing chanoclavine-I. 
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These results support previous knockout data indicating that both easE and easC are required for 
chanoclavine-I synthesis from N-Me-DMAT [9]. A metabolite of undetermined structure accumulated 
to relatively high levels in the WFC transformant; this metabolite was not detectable in extracts of the 
A. nidulans WFE strain. Improved strains or altered growth conditions will be necessary to increase 
yield of the compound for the purpose of collecting adequate material for structure determination. The 
WFC analyte could potentially be the next intermediate downstream of N-Me-DMAT, in which case 
easC would code for the enzyme involved in the third step of ergot alkaloid synthesis. Considering its 
catalase activity, one proposed function for EasC is detoxification of hydrogen peroxide produced 
from the oxidative activities of EasE [9], in which case EasC would not act directly on an ergot 
alkaloid substrate; however, comparison of the alkaloid profiles of WFE and WFC mutants indicates 
that EasC can act independent of EasE and chemically modifies an ergot alkaloid substrate. In a 
previous study, easE was knocked out in A. fumigatus, creating a strain of A. fumigatus that lacked 
easE but contained easC [9]. N-Me-DMAT was detected in cultures of the easE knockout strain, but 
the novel metabolite from the A. nidulans WFC strain was not observed. One potential explanation for 
this apparent discrepancy is that the A. fumigatus easE knockout mutant contained downstream 
enzymes in the ergot alkaloid pathway that may have altered its ergot alkaloid profile. Alternatively, 
the difference between alkaloid profiles of A. fumigatus easE knockout and A. nidulans WFC could be 
due to other factors in the species backgrounds in which N-Me-DMAT accumulated. It is presently 
unknown whether the observed WFC analyte is an actual, on-pathway intermediate or whether it is a 
byproduct of EasC acting out of sequence on a compound that is not ordinarily its substrate. Feeding 
studies with the unidentified analyte and strains expressing defined sets of ergot alkaloid synthesis 
genes would be a reasonable approach to test the involvement of this compound in the ergot alkaloid 
pathway. Again, greater quantities of the analyte would be required for such studies. An in vitro 
approach involving separate and combined enzymes also would help to fully understand the functions 
of these enzymes. Difficulty with expressing EasE in active form in vitro has slowed studies of 
catalytic function of this enzyme [9].  
The approach of expressing genes in A. nidulans may be applied to other genes in the pathway to 
study their roles in the biosynthesis of ergot alkaloids (as was recently reviewed by Chiang et al. [16] 
for other fungal secondary metabolite pathways). Heterologous expression in A. nidulans also should 
be applicable to studying genes from ergot alkaloid pathways of other fungi, such as those genes from 
lineage-specific branches of the pathway. In such cases, it may be necessary to replace the native 
promoters of those heterologous genes with promoters from A. fumigatus eas genes or strong  
A. nidulans promoters.  
4. Experimental Section  
4.1. Fungal Strains and Growth Conditions  
Aspergillus fumigatus isolate Af293, as a source of genomic DNA, was grown in malt extract broth 
(15 g malt extract/L) overnight at 37 °C. The uridine auxotrophic A. nidulans isolate FGSC A767 
(Fungal Genetic Stock Center, Kansas City, MO, USA) was grown at 37 °C on SYE medium  
(20 g/L sucrose, 10 g/L yeast extract, 10 g/L MgSO4, 2 mL/L trace element solution [17],  
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2.2 g/L uracil, 2.2 g/L uridine, with or without 15 g/L agar). For preparation of protoplasts, A. nidulans 
was grown in liquid SYE medium overnight. Transformants were regenerated on selective SYE agar 
medium which did not contain uracil or uridine and was supplemented with 304 g/L sucrose (to serve 
as osmoticum as well as carbon source). To test alkaloid accumulation, cultures were grown on SYE 
agar medium at 37 °C for one week.  
4.2. DNA Manipulations  
DNA was extracted from A. fumigatus according to the protocol described by Richards et al. [18]. 
An 8774-bp fragment containing dmaW, easF, easC, and easE was amplified by PCR primed with 
oligonucleotides primer 1 (5'-TACCTATACCTAATCGAAGCCGCACGCAGTGCACC-3') and primer 
2 (5'-GCCGCCCATTCACCAAGATTTTTGCACAAATCTGCG-3'). A 25 μL reaction contained 1× 
LongAmp Taq reaction buffer, 200 μM of each deoxynucleotide triphosphate, 1 μM of each primer, 
and 2.5 units LongAmp Taq DNA polymerase (New England BioLabs, Ipswich, MA, USA). The 
reaction began with an initial denaturing step of 3 min at 94 °C, followed by 35 cycles of 30 s at 94 °C 
and 10 min at 65 °C, with a final extension of 5 min at 65 °C.  
A 6123-bp fragment containing dmaW, easF, and easE was amplified by PCR primed with 
oligonucleotides primer 3 (5'-GAGAGCTACTTGACATATTGTGTCGGCAGGTGCGCA-3') and 
primer 2 (5'-GCCGCCCATTCACCAAGATTTTTGCACAAATCTGCG-3'). The PCR conditions 
were the same as stated above except the elongation time was 7 min.  
In order to generate transformant WFC (containing dmaW, easF, and easC), two separate DNA 
fragments were amplified for co-transformation. The first fragment containing dmaW and easC was 
primed with primer 1 (5'-TACCTATACCTAATCGAAGCCGCACGCAGTGCACC-3') and primer 5 
(5'-CTACTCCATTGTCCTGTGAGTTG-3') which primed amplification of a 4846-bp fragment. The 
PCR conditions were the same as stated above except the elongation time was 5 min. The second 
fragment (2943 bp) contained only easF and was amplified by PCR primed with oligonucleotides 
easFF (5'-TCCATTCTTCGCTCGTTCAACCAGCAGG-3') and easFR (5'-CAGGACCTGTACCT 
AAAGCCTGGTAACC-3') in a 25 μL reaction containing 1× GoTaq Flexi buffer, 200 μM each 
deoxynucleotide triphosphate, 1.5 mM MgCl2, 1 μM of each primer, and 2.5 units of Taq DNA 
polymerase (Promega, Madison, WI, USA). The reaction began with an initial denaturing step of 3 min 
at 94 °C, followed by 35 cycles of 30 s at 94 °C, 30 s at 55 °C, and 3 min at 72 °C, with a final 
extension of 5 min at 72 °C. 
PCR products were purified with QIAquick gel extraction kits (Qiagen, Valencia, CA, USA) prior 
to their inclusion in fungal transformations. The selectable marker pPyrG was obtained from the 
Fungal Genetics Stock Center and was digested with XhoI (New England BioLabs, Ipswich, MA, 
USA) and purified with QIAquick gel extraction kit prior to transformation. 
4.3. Fungal Transformation and Screening  
Protoplasts of A. nidulans FGSC A767 were prepared by incubating overnight cultures with 50 mg 
driselase (Sigma-Aldrich, St. Louis, MO, USA), which was filter sterilized with a 0.22 μm filter, and 
75 mg lysing enzyme (Sigma-Aldrich, St. Louis, MO, USA) in 15 mL of 0.7 M sodium chloride. 
Protoplasts were purified and co-transformed with PCR product and selectable marker (pPyrG) as 
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described by Coyle et al. [19]. Protoplasts were plated on SYE agar medium containing no uracil or 
uridine. Transformation plates were incubated at 37 °C, and transformants were collected 
approximately three days after transformation.  
Each transformant was screened by PCR for the presence or absence of dmaW, easF, easC, and 
easE. An internal region of dmaW was primed with dmaWF (5'-TTGATCTGGAGTGGTTCCGC-3') 
and dmaWR (5'-CGTTCATGCCGAAGGTTGTG-3') yielding a 651-bp fragment. Primers for 
amplifying an internal region of easE were easEF (5'-CCAGATACATTGCCATCGCATG-3') and 
easER (5'-TGTTCCAACTGCTTGGCCAGAT-3'), which primed amplification of a 897-bp fragment. 
The presence or absence of easC was tested by PCR with primers easCF  
(5'-GAATTCGAGGTATTGATCTCC-3') and easCR (5'-AGCCAGGCAAAGATCCATAGTT-3') 
which flank a 1036-bp fragment. An internal region of easF was primed with easFF  
(5'-AAGTTGTCGAAGGTCTCACGAA-3') and easFR (5'-GTGATTAGAGATGCTTCTGTC-3'), 
yielding an 820-bp fragment. Each of these PCRs were 25 μL reactions containing 1× GoTaq Flexi 
buffer, 200 μM deoxynucleotide triphosphate, 1.5 mM MgCl2, 1 μM of each primer, and 2.5 units of 
Taq DNA polymerase (Promega, Madison, WI, USA). PCR conditions began with an initial denaturing 
step of 3 min at 94 °C, followed by 35 cycles of 30 s at 94 °C followed by 30 s at 55 °C, and 1 min and 
30 s at 72 °C, followed by a final extension of 5 min at 72 °C. 
4.4. HPLC Analyses  
Transformants positive for the presence of the target genes were analyzed by HPLC for the 
accumulation of chanoclavine-I. Ergot alkaloids were extracted by incubating a spore-rich sample of 
the colony, containing approximately 1 cm2 of culture surface area, in 400 μL of methanol for 30 min 
and clarifying the extract by centrifugation. Extracts were injected into a C18 column (Prodigy 5-μm 
ODS3 (150 mm by 4.6 mm); Phenomenex, Torrance, CA, USA) and subjected to a multilinear binary 
gradient from 5% (v/v) acetonitrile plus 95% (v/v) aqueous 50 mM ammonium acetate to 75% 
acetonitrile plus 25% aqueous 50 mM aqueous ammonium acetate at a flow rate 1 mL/min, as 
previously described [15]. Ergot alkaloids were detected using two fluorescence settings. The first 
setting had an excitation wavelength of 272 nm and emission wavelength of 372 nm; the second 
setting was 310 nm (excitation) and 410 nm (emission). Chanoclavine-I (generously provided by Brian 
Tapper, AgResearch, New Zealand) and N-Me-DMAT (gift from Sarah O’Connor, University of East 
Anglia) were run as standards. Peaks of interest were isolated from the HPLC by collecting the runoff 
from the discard tube for 30 s after the peak was visualized on the detector.  
4.5. LC-MS Analyses  
Ergot alkaloid extracts were prepared by washing the surface of a conidiating colony with 2 mL of 
methanol, rotating the extract at 30 rpm for 30 min, and then clarifying the extract by centrifugation. 
Clarified extracts were then concentrated to a volume of 50 μL in a speed-vac apparatus, and 10 μL of 
concentrated extract were injected into the LC-MS. To isolate individual analytes, concentrated 
extracts were analyzed by fluorescence HPLC, peaks were collected manually, and concentrated to a 
volume of 50 μL in a speed-vac apparatus prior to LC-MS analysis. Concentrated samples were 
analyzed on a Finnigan LCQDecaXP plus mass spectrometer equipped with a Surveyor HPLC system. 
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Analytes were separated on a C18 column (Phenomenex 4-μm polar-RP (150 mm by 2 mm)), 
maintained at 30 °C, by combining mobile phases A (5% acetonitrile, 0.1% formic acid) and B (75% 
acetonitrile, 0.1% formic acid). Initial conditions were 86% A + 14% B, which ramped linearly to 73% 
A + 27% B at 25 min, 25% A + 75% B at 40 min, and 0% A + 100% B at 42 min. The flow rate was 
200 μL/min. Analytes were ionized by electrospray ionization in positive mode and were detected by 
scanning for ions with a m/z between 200–400.  
5. Conclusions  
Four genes common to all ergot alkaloid synthesis gene clusters—dmaW, easF, easE, and  
easC—are sufficient to direct synthesis of chanoclavine-I in A. nidulans. Both easC and easE are 
required for the synthesis of chanoclavine-I from N-Me-DMAT, but neither alone is sufficient. 
Aspergillus nidulans is a suitable heterologous host for expressing ergot alkaloids synthesis genes.  
Acknowledgments 
This research was conducted with funding from the U.S. Department of Agriculture National 
Institute of Food and Agriculture (2012-67013-19384). We thank Sarah O’Connor (University of East 
Anglia) for helpful discussions and Brian Tapper (AgResearch, New Zealand) and Sarah O’Connor for 
standards. This article is published with permission of the West Virginia Agriculture and Forestry 
Experiment Station as scientific article number 3156.  
Conflict of Interest 
The authors declare no conflict of interest.  
References 
1. Lorenz, N.; Haarmann, T.; Pažoutová, S.; Jung, M.; Tudzynski, P. The ergot alkaloid gene cluster: 
Functional analyses and evolutionary aspects. Phytochemistry 2009, 70, 1822–1832. 
2. Panaccione, D.G. Ergot Alkaloids. In The Mycota, Industrial Applications, 2nd ed.;  
Hofrichter, M., Ed.; Springer-Verlag: Berlin, Germany, 2010; Volume X, pp. 195–214.  
3. Wallwey, C.; Li, S.-M. Ergot alkaloids: Structure diversity, biosynthetic gene clusters and 
functional proof of biosynthetic genes. Nat. Prod. Rep. 2011, 28, 496–510. 
4. Schardl, C.L.; Young, C.A.; Hesse, U.; Amyotte, S.G.; Andreeva, K.; Calie, P.J.;  
Fleetwood, D.J.; Haws, D.C.; Moore, N.; Oeser, B.; et al. Plant-symbiotic fungi as chemical 
engineers: Multi-genome analysis of the Clavicipitaceae reveals dynamics of alkaloid loci. PLoS 
Genet. 2013, in press.  
5. Kozikowski, A.P.; Chen, C.; Wu, J.-P.; Shibuya, M.; Kim, C.-G.; Floss, H.G. Probing ergot 
alkaloid biosynthesis: Intermediates in the formation of ring C. J. Am. Chem. Soc. 1993, 115, 
2482–2488. 
6. Wang, J.; Machado, C.; Panaccione, D.G.; Tsai, H.-F.; Schardl, C.L. The determinant step in 
ergot alkaloid biosynthesis by an endophyte of perennial ryegrass. Fungal Genet. Biol. 2004, 41, 
189–198. 
Toxins 2013, 5 455 
 
 
7. Rigbers, O.; Li, S.-M. Ergot alkaloid biosynthesis in Aspergillus fumigatus: Overproduction and 
biochemical characterization of a 4-dimethylallyltryptophan N-methyltransferase. J. Biol. Chem. 
2008, 283, 26859–26868. 
8. Lorenz, N.; Olšovská, J.; Šulc, M.; Tudzynski, P. Alkaloid cluster gene ccsA of the ergot fungus 
Claviceps purpurea encodes chanoclavine I synthase, a flavin adenine dinucleotide-containing 
oxidoreductase mediating the transformation of N-methyl-dimethylallyltryptophan to chanoclavine 
I. Appl. Environ. Microbiol. 2010, 76, 1822–1830. 
9. Goetz, K.E.; Coyle, C.M.; Cheng, J.Z.; O’Connor, S.E.; Panaccione, D.G. Ergot cluster-encoded 
catalase is required for synthesis of chanoclavine-I in Aspergillus fumigatus. Curr. Genet. 2011, 
57, 201–211. 
10. Unsöld, I.A.; Li, S.-M. Overproduction, purification and characterization of FgaPT2, a 
dimethylallyltryptophan synthase from Aspergillus fumigatus. Microbiology 2005, 151, 1499–1505. 
11. Coyle, C.M.; Panaccione, D.G. An ergot alkaloid biosynthesis gene and clustered hypothetical 
genes from Aspergillus fumigatus. Appl. Environ. Microbiol. 2005, 71, 3112–3118. 
12. Latgé, J.-P. Aspergillus fumigatus and aspergillosis. Clin. Microbiol. Rev. 1999, 12, 310–350. 
13. Coyle, C.M.; Kenaley, S.C.; Rittenour, W.R.; Panaccione, D.G. Association of ergot alkaloids 
with conidiation in Aspergillus fumigatus. Mycologia 2007, 99, 804–811. 
14. Twumasi-Boateng, K.; Yu, Y.; Chen, D.; Gravelat, F.N.; Nierman, W.C.; Sheppard, D.C. 
Transcriptional profiling identifies a role for BrlA in the response to nitrogen depletion and for 
StuA in the regulation of secondary metabolite clusters in Aspergillus fumigatus. Eukaryot. Cell 
2009, 8, 104–115. 
15. Panaccione, D.G.; Ryan, K.L.; Schardl, C.L.; Florea, S. Analysis and modification of ergot 
alkaloid profiles in fungi. Method. Enzymol. 2012, 515, 267–290. 
16. Chiang, Y.M.; Chang, S.L.; Oakley, B.R.; Wang, C.C.C. Recent advances in awakening silent 
biosynthetic gene clusters and linking orphan clusters to natural products in microorganisms. 
Curr. Opin. Chem. Biol. 2011, 15, 137–143. 
17. Hunter, S.H.; Provasoli, L.; Schatz, A.; Haskins, C.P. Some approaches to the study of the role of 
metals in the metabolism of microorganisms. Am. Philos. Soc. Proc. 1950, 94, 152–170.  
18. Richards, E.; Reichardt, M.; Rogers, S. Preparation of genomic DNA from plant tissue.  
Curr. Protoc. Mol. Biol. 2001, 27, 2.3.1–2.3.7. 
19. Coyle, C.M.; Cheng, J.Z.; O’Connor, S.E.; Panaccione, D.G. An old yellow enzyme gene controls 
the branch point between Aspergillus fumigatus and Claviceps purpurea ergot alkaloid pathways. 
Appl. Environ. Microbiol. 2010, 76, 3898–3903. 
© 2013 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/3.0/). 
